Cabot Corporation supplies specialty chemicals and materials for global industry, with key offerings in reinforcement and purification.
Shares of Cabot Corporation (NYSE: CBT - Get Free Report) have been assigned a consensus recommendation of "Hold" from the six brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating on
Cabot (CBT) reported earnings 30 days ago. What's next for the stock?
Cabot closes its $70M MXCB deal in Mexico, adding a carbon black plant near Altamira to boost efficiencies and serve tire and rubber customers.
Cabot Corporation (CBT) Q1 2026 Earnings Call Transcript
CBT's fiscal Q1 earnings beat estimates despite lower sales, as Reinforcement Materials demand stayed weak and full-year EPS guidance was narrowed.
Cabot (CBT) came out with quarterly earnings of $1.53 per share, beating the Zacks Consensus Estimate of $1.4 per share. This compares to earnings of $1.76 per share a year ago.
Cabot inks a multi-year deal with PowerCo to supply conductive battery materials, strengthening its push into Europe's fast-growing EV battery market.
Cabot (CBT) reported earnings 30 days ago. What's next for the stock?
Investors need to pay close attention to Cabot stock based on the movements in the options market lately.
Cabot (CBT) hasn't been in the spotlight lately, but its current setup may warrant a closer look. The specialty chemicals company has quietly built a strong financial base while its stock remains meaningfully discounted from recent highs.
CBT's Q4 earnings miss estimates as weaker demand and volumes weighed on sales.